Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jaross

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Kinderarztliche Praxis|March 1, 1980
[Triglyceride and cholesterol levels in serum of healthy children]M Baehrecke, W Jaross, T Leistner, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjectsS Gehrisch, M Steinke, H Kostka, et al.
Zeitschrift Fur Medizinische Laboratoriumsdiagnostik|January 1, 1989
[Peculiarities in the hypophyseal and sex hormone balance in males following survival of myocardial infarct]W Jaross, K Schollberg, E Seiler, et al.
Human Mutation|September 30, 1999
New missense mutation in exon 13 (N789T) of the coagulation factor V geneH Kostka, G Siegert, S Gehrisch, et al.
Toxicology Letters|November 20, 1998
Food supply abundant increase of serum selenium concentrations in middle-aged Dresden women between 1990 and 1996. DRECAN-Team. Dresden Cardiovascular Risk and NutritionS Bergmann, V Neumeister, R Siekmeier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 21, 2000
Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein CG Siegert, H Kostka, S Gehrisch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Expression of secretory group IIA phospholipase A(2) in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissuesM Menschikowski, A Rosner-Schiering, R Eckey, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Investigation of genotype-dependent differences in factor V activity as well as response to activated protein C by application of different methodsG Siegert, H Kostka, E Kuhlisch, et al.
Biomedica Biochimica Acta|January 1, 1988
Is the level of steroid hormones in the low density lipoprotein (LDL) particles responsible for the prostaglandin I2 inhibitory potency of LDL?J Beitz, K Schollberg, S Fischer, et al.
Arzneimittel-Forschung|December 1, 1988
Effects of a bezafibrate sustained release formulation on plasma lipoproteins in patients with hypercholesterolemia. Importance of timing of tablet intake for efficacyM Hanefeld, P D Lang, S Fischer, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Kinderarztliche Praxis|March 1, 1980
[Triglyceride and cholesterol levels in serum of healthy children]M Baehrecke, W Jaross, T Leistner, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjectsS Gehrisch, M Steinke, H Kostka, et al.
Zeitschrift Fur Medizinische Laboratoriumsdiagnostik|January 1, 1989
[Peculiarities in the hypophyseal and sex hormone balance in males following survival of myocardial infarct]W Jaross, K Schollberg, E Seiler, et al.
Human Mutation|September 30, 1999
New missense mutation in exon 13 (N789T) of the coagulation factor V geneH Kostka, G Siegert, S Gehrisch, et al.
Toxicology Letters|November 20, 1998
Food supply abundant increase of serum selenium concentrations in middle-aged Dresden women between 1990 and 1996. DRECAN-Team. Dresden Cardiovascular Risk and NutritionS Bergmann, V Neumeister, R Siekmeier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 21, 2000
Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein CG Siegert, H Kostka, S Gehrisch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Expression of secretory group IIA phospholipase A(2) in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissuesM Menschikowski, A Rosner-Schiering, R Eckey, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Investigation of genotype-dependent differences in factor V activity as well as response to activated protein C by application of different methodsG Siegert, H Kostka, E Kuhlisch, et al.
Biomedica Biochimica Acta|January 1, 1988
Is the level of steroid hormones in the low density lipoprotein (LDL) particles responsible for the prostaglandin I2 inhibitory potency of LDL?J Beitz, K Schollberg, S Fischer, et al.
Arzneimittel-Forschung|December 1, 1988
Effects of a bezafibrate sustained release formulation on plasma lipoproteins in patients with hypercholesterolemia. Importance of timing of tablet intake for efficacyM Hanefeld, P D Lang, S Fischer, et al.
Pageof 10